Strategic and Scientific Advisory Board 

Winfred W. Williams, MD

Winfred W. Williams, MD, Medical Advisor, is Nephrologist and Associate Chief of the Division of Nephrology at MGH/HMS. He is Director of the Program in Interventional Nephrology for the Transplantation Unit at MGH.

Dr. Williams is the Associate Chief of the MGH Division of Nephrology and Founding Director of the MGH Center for Diversity and Inclusion. Dr. Williams has a long, foundational track record at MGH in the development of programs to enhance the diversity of the physician workforce here and at Harvard Medical School (HMS).

Over the past two decades, he has helped develop critical initiatives to support hospital-wide diversity goals. Dr. Williams graduated from Harvard College, cum laude, with a B.A. in Biochemical Sciences. He went on to medical school at the New York University School of Medicine and completed his residency and fellowship training at Brigham and Women’s Hospital. He is a nationally and internationally recognized expert in health policy addressing disparities in the care of end stage renal disease and organ transplantation. He is currently serving (and has served) on several national committees addressing key policy issues in nephrology and transplantation and is past chair of the AST and OPTN/UNOS Minority Affairs Committees and member of the Board of Directors at UNOS, the governing body for organ allocation in the U.S.

In his research endeavors, Dr. Williams’ most recent work focuses on transplantation across select ABO incompatible blood groups to increase access to transplantation for ethnic minority patients. The findings of his 2015 landmark study—published as the cover article for the Amer J of Transplantation—helped provide the basis for a new kidney allocation algorithm, resulting in an increase in the rate of transplantation for ethnic minority patients in the US.

Other Team Members

Sylvie Breton

Professor Sylvie Breton, PhD, is a Professor of Medicine at Harvard Medical School, and directs the Breton Laboratory within the Program in Membrane Biology / Center for Systems Biology in the Nephrology Division at the Massachusetts General Hospital.

View bio

Glenn Batchelder

Mr. Glenn Batchelder previously was Co-Founder and CEO of Civitas Therapeutics, a development stage pulmonary delivery therapeutic company based on the ARCUS technology platform that was sold to Acorda Therapeutics.

View bio

John Randle

Dr. John C.R. Randle, PhD, brings over 30 years of practical, hands-on experience to the business of drug candidate selection and development.

View bio

Andrea Franz

Ms. Franz is a financial executive with over 25 years of experience in small to mid-size biotechnology companies.

View bio

Dennis Ausiello, MD

Dennis A. Ausiello, MD, is the Director of the Center for Assessment Technology and Continuous Health (CATCH) at MGH; Jackson Distinguished Professor of Clinical Medicine, Emeritus at Harvard Medical School; and the Physician-in-Chief, Emeritus of the Department of Medicine at MGH.

View bio

Dennis Brown, PhD

Prof. Dennis Brown is an internationally recognized expert on renal physiology and kidney function at the Massachusetts General Hospital (Nephrology Division) and Harvard Medical School.

View bio

Martin Freed, MD

Dr. Martin Freed brings more than 25 years of strategic development and operational expertise from across the biopharmaceutical and life sciences industries.

View bio

Todd Rosengart, MD

Dr. Todd Rosengart is a nationally recognized cardiothoracic surgeon, a National Institutes of Health (NIH)-supported scientist, and an extensively published investigator.

View bio

Sushrat Waikar, MD, Mph

Sushrut Waikar, MD, MPH, Clinical Advisor, is Associate Professor of Medicine, BWH/HMS. He is Director of Translational Research and Ambulatory Services, BWH and is an expert in acute and chronic kidney disease.

View bio